Core Viewpoint - The company, Lionhead Technology Development Co., Ltd., has announced its third-quarter report for 2025, which includes significant financial data and a proposed acquisition of a majority stake in Hangzhou Lipo Technology Co., Ltd. [9][15] Financial Data Summary - The third-quarter financial report has not been audited [3][7] - The report includes major accounting data and financial indicators, although specific figures are not detailed in the provided text [3][4] Shareholder Information - The company plans to acquire 97.4399% of Hangzhou Lipo Technology from 14 counterparties through a combination of issuing shares and cash payments [6][15] - The acquisition has been approved by the company's board and is pending regulatory approvals from the Shanghai Stock Exchange and the China Securities Regulatory Commission [6][17] Meeting Resolutions - The company's board of directors held a meeting on October 24, 2025, where the third-quarter report was unanimously approved [9][12] - The supervisory board also convened on the same day and approved the report, confirming compliance with legal and regulatory requirements [12][9] Regulatory Compliance - The company has received an inquiry letter from the Shanghai Stock Exchange regarding the asset purchase and fundraising, requiring a written response within a specified timeframe [15][16] - The company has applied for an extension to respond to the inquiry, indicating the complexity of the matters involved [17]
狮头科技发展股份有限公司 2025年第三季度报告